<DOC>
	<DOCNO>NCT02860052</DOCNO>
	<brief_summary>This phase 2 , multi-center , double-blind , randomize , vehicle-controlled study conduct approximately 170 non immunocompromised adult subject interdigital tinea pedis . Subjects apply investigational product ( IP ) ( SB208 Vehicle Gel ) interdigital area affect immediate surround area one foot daily 2 week , follow 4-week post-treatment observation period .</brief_summary>
	<brief_title>SB208 Treatment Tinea Pedis</brief_title>
	<detailed_description />
	<mesh_term>Tinea</mesh_term>
	<mesh_term>Tinea Pedis</mesh_term>
	<criteria>Otherwise healthy male female subject clinical diagnosis interdigital t. pedis T.pedis provisionally confirm baseline positive KOH wet mount segment fungal hypha skin scrap target site Women pregnant nursing plan become pregnant Subjects onychomycosis moccasintype t. pedis Subjects use topical systemic antifungal agent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>